AU2001271018A1 - Gpr14 antagonist - Google Patents
Gpr14 antagonistInfo
- Publication number
- AU2001271018A1 AU2001271018A1 AU2001271018A AU7101801A AU2001271018A1 AU 2001271018 A1 AU2001271018 A1 AU 2001271018A1 AU 2001271018 A AU2001271018 A AU 2001271018A AU 7101801 A AU7101801 A AU 7101801A AU 2001271018 A1 AU2001271018 A1 AU 2001271018A1
- Authority
- AU
- Australia
- Prior art keywords
- gpr14 antagonist
- gpr14
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-206865 | 2000-07-04 | ||
JP2000206865 | 2000-07-04 | ||
PCT/JP2001/005784 WO2002002530A1 (en) | 2000-07-04 | 2001-07-04 | Gpr14 antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001271018A1 true AU2001271018A1 (en) | 2002-01-14 |
Family
ID=18703723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001271018A Abandoned AU2001271018A1 (en) | 2000-07-04 | 2001-07-04 | Gpr14 antagonist |
Country Status (5)
Country | Link |
---|---|
US (1) | US20040063699A1 (en) |
EP (1) | EP1310490A4 (en) |
AU (1) | AU2001271018A1 (en) |
CA (1) | CA2414976A1 (en) |
WO (1) | WO2002002530A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040016844A (en) | 2001-03-27 | 2004-02-25 | 액테리온 파마슈티칼 리미티드 | 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ⅱ receptors antagonists |
DE60207894T2 (en) | 2001-12-04 | 2006-07-20 | Actelion Pharmaceuticals Ltd. | 4- (PIPERIDYL- AND PYRROLIDYL-ALKYL-UREIDO) -QUINOLINES AS UROTENSIN II RECEPTOR ANTAGONISTS |
RU2423353C1 (en) | 2002-12-20 | 2011-07-10 | Глэксо Груп Лимитед | New benzazepin derivatives |
RU2006113948A (en) | 2003-09-26 | 2007-11-10 | Актелион Фармасьютиклз Лтд. (Ch) | PYRIDINE DERIVATIVES AND THEIR APPLICATION AS UROTENZINE II ANTAGONISTS |
RU2397978C2 (en) | 2004-10-12 | 2010-08-27 | Актелион Фармасьютиклз Лтд | 1-[2-(4-benzyl-4-hydroxypiperidin-1-yl)-ethyl]-3-(2-methylquinolin-4-yl)-urea in crystalline sulphate form |
US7741317B2 (en) * | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
US7790745B2 (en) * | 2005-10-21 | 2010-09-07 | Bristol-Myers Squibb Company | Tetrahydroisoquinoline LXR Modulators |
US10357493B2 (en) | 2017-03-10 | 2019-07-23 | Selenity Therapeutics (Bermuda), Ltd. | Metalloenzyme inhibitor compounds |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA792044B (en) * | 1978-05-08 | 1980-05-28 | Scherico Ltd | Substituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof,and pharmaceutical compositions containing them |
US4284555A (en) * | 1979-04-27 | 1981-08-18 | Schering Corporation | 7-Chloro-8(substituted amino carbonyloxy)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
TW197435B (en) * | 1990-11-22 | 1993-01-01 | Takeda Pharm Industry Co Ltd | |
TW218875B (en) * | 1992-03-09 | 1994-01-11 | Takeda Pharm Industry Co Ltd | |
US5462934A (en) * | 1992-03-09 | 1995-10-31 | Takeda Chemical Industries | Condensed heterocyclic ketone derivatives and their use |
US6159700A (en) * | 1997-01-27 | 2000-12-12 | Smithkline Beecham Corporation | Method of finding agonist and antagonist to human and rat GPR14 |
US5851798A (en) * | 1997-01-27 | 1998-12-22 | Smithkline Beecham Corporation | Nucleic acid encoding human GPR14 receptor |
WO1998046590A1 (en) * | 1997-04-17 | 1998-10-22 | Takeda Chemical Industries, Ltd. | Thermogenic composition and benzazepine thermogenics |
EP1122252A4 (en) * | 1998-10-16 | 2002-06-26 | Takeda Chemical Industries Ltd | Nitrogenous fused heterocycle compounds, process for the preparation thereof and agents containing the same |
EP1136503A1 (en) * | 1998-11-30 | 2001-09-26 | Takeda Chemical Industries, Ltd. | Novel physiologically active substance, process for producing the same and utilization thereof |
WO2001018054A1 (en) * | 1999-07-23 | 2001-03-15 | Smithkline Beecham Corporation | Monkey gpr14 |
DE60015187T2 (en) * | 1999-12-21 | 2005-02-17 | Smithkline Beecham Corp. | UROTENSIN-II RECEPTOR ANTAGONISTS |
WO2001045694A1 (en) * | 1999-12-21 | 2001-06-28 | Smithkline Beecham Corporation | Urotensin-ii receptor antagonists |
ATE249831T1 (en) * | 1999-12-21 | 2003-10-15 | Smithkline Beecham Corp | CARBOXAMIDE DERIVATIVES OF PYRROLIDINE AND PIPERIDINE AS UROTENSIN-II RECEPTOR ANTAGONISTS |
AU2001256733A1 (en) * | 2000-05-16 | 2001-11-26 | Takeda Chemical Industries Ltd. | Melanin-concentrating hormone antagonist |
EP1295867A4 (en) * | 2000-06-28 | 2005-03-30 | Takeda Pharmaceutical | Biphenyl compound |
-
2001
- 2001-07-04 CA CA002414976A patent/CA2414976A1/en not_active Abandoned
- 2001-07-04 AU AU2001271018A patent/AU2001271018A1/en not_active Abandoned
- 2001-07-04 EP EP01949909A patent/EP1310490A4/en not_active Withdrawn
- 2001-07-04 WO PCT/JP2001/005784 patent/WO2002002530A1/en not_active Application Discontinuation
- 2001-07-04 US US10/332,023 patent/US20040063699A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040063699A1 (en) | 2004-04-01 |
EP1310490A4 (en) | 2004-03-17 |
WO2002002530A1 (en) | 2002-01-10 |
EP1310490A1 (en) | 2003-05-14 |
CA2414976A1 (en) | 2002-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001262847A1 (en) | Language-understanding | |
AU2001292739A1 (en) | 1-oxorapamycins | |
AU2000267458A1 (en) | Hypercomputer | |
AU2001254546A1 (en) | Aminopiperidines | |
AU2001288040A1 (en) | Homeostasis-maintaining agents | |
AU2002214284A1 (en) | Anti-helicobacterial agents | |
AU2001239310A1 (en) | Decahydro-isoquinolines | |
AU2001220246A1 (en) | Neckphone | |
AU2002211620A1 (en) | Autoanastomosis | |
AU2001258349A1 (en) | Bisacylguanidine | |
AU2001296577A1 (en) | Chlorophyllases | |
AU2001279754A1 (en) | Indoloquinazolinones | |
AU2002211128A1 (en) | Step-bike | |
AU2001285886A1 (en) | 2-guanidino-4-aryl-quinazoline | |
AU2001290931A1 (en) | Ski-snowboard | |
AU2001265871A1 (en) | Substituted sulfonylaminopyrimidines | |
AU2001293852A1 (en) | Sulfonylguanidine | |
AU2001258924A1 (en) | Microsatellite-aflp | |
AU2001254731A1 (en) | Substituted phenyluracils | |
AU2001258255A1 (en) | Substituted benzoylcyclohexenones | |
AU2001271018A1 (en) | Gpr14 antagonist | |
AU2001240605A1 (en) | Endoparasiticidal agents | |
AU2001281921A1 (en) | Bdellosomes | |
AU2001295398A1 (en) | Endothelin antagonist | |
AU2001246864A1 (en) | Hypotensors |